VEA
VTAE

Virtus ETF Advisers’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Virtus ETF Advisers’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-24,463
Closed -$512K – 205
2016
Q3 		$512K Hold
24,463
– – 0.25% 70
2016
Q2 		$264K Buy
24,463
+6,933
+40% +$59.3K 0.2% 77
2016
Q1 		$116K Buy
+17,530
New +$159K 0.16% 140

Virtus ETF Advisers's VTAE Position: Q4 2016 in Review

Virtus ETF Advisers sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 24,463 shares — an estimated $512K sold.

Virtus ETF Advisers first reported a position in VTAE in Q1 2016 and held it in 3 quarters. The position peaked at $512K in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

  • Virtus ETF Advisers reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
  • Virtus ETF Advisers sold 24,463 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $512K.
  • Virtus ETF Advisers first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q1 2016 and held it in 3 quarters.
  • Virtus ETF Advisers's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $512K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Virtus ETF Advisers's 13F filing for Q4 2016, filed 14 Feb 2017.